I think that if they have the 12 months of satisfactory efficacy and safety data that is sufficient. The second 12 months constitutes extended safety monitoring. At least that is what I understand from the announcements and the company has had extensive consultations with the FDA.
I think that if they have the 12 months of satisfactory efficacy...
Add OPT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
61.0¢ |
Change
0.075(14.0%) |
Mkt cap ! $750.9M | |||
| Open | High | Low | Value | Volume |
| 55.0¢ | 61.0¢ | 54.0¢ | $3.300M | 5.637M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 13666 | 60.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 61.0¢ | 47448 | 2 |
View Market Depth
| Last trade - 16.10pm 09/09/2024 (20 minute delay) ? |
| OPT (ASX) Chart |